Tom Van Nieuwenhuysen

Tom Van Nieuwenhuysen

UNVERIFIED PROFILE

Are you Tom Van Nieuwenhuysen?   Register this Author

Register author
Tom Van Nieuwenhuysen

Tom Van Nieuwenhuysen

Publications by authors named "Tom Van Nieuwenhuysen"

Are you Tom Van Nieuwenhuysen?   Register this Author

5Publications

134Reads

34Profile Views

Targeted Genome Engineering in Xenopus Using the Transcription Activator-Like Effector Nuclease (TALEN) Technology.

Methods Mol Biol 2018 ;1865:55-65

Department of Biomedical Molecular Biology, Ghent University, Ghent, Belgium.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/978-1-4939-8784-9_4
Publisher Site
http://dx.doi.org/10.1007/978-1-4939-8784-9_4DOI Listing
May 2019

TALENs and CRISPR/Cas9 fuel genetically engineered clinically relevant Xenopus tropicalis tumor models.

Genesis 2017 01;55(1-2)

Developmental Biology Unit, Department of Biomedical Molecular Biology, Ghent University, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/dvg.23005DOI Listing
January 2017

TALEN-mediated apc mutation in Xenopus tropicalis phenocopies familial adenomatous polyposis.

Oncoscience 2015 19;2(5):555-66. Epub 2015 May 19.

Developmental Biology Unit, Department of Biomedical Molecular Biology, Ghent University, Ghent, Belgium ; Center for Medical Genetics, Ghent University and Ghent University Hospital, Ghent, Belgium.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4468341PMC
http://dx.doi.org/10.18632/oncoscience.166DOI Listing
June 2015

TLR2 activation causes no morbidity or cardiovascular failure, despite excessive systemic nitric oxide production.

Cardiovasc Res 2013 Oct 19;100(1):28-35. Epub 2013 Jun 19.

Department for Molecular Biomedical Research, VIB, Technologiepark 927, Ghent B-9052, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/cvr/cvt168DOI Listing
October 2013